Condition
Nasal Allergy
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06858423Phase 4CompletedPrimary
Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients
NCT06021002Not ApplicableUnknown
Nasal Immune Challenge Study
NCT05301647Completed
Mometasone Furoate Nasal Spray in Italian Children
NCT01925729Phase 1Completed
TransMEM Gas Exchange -- Project 1, Aim 2
NCT03039101Not ApplicableCompletedPrimary
Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects
Showing all 5 trials